Colorectal Cancer | Specialty

The OncLive Colorectal Cancer condition center page is a comprehensive resource for clinical news and expert insights on colorectal cancer treatment and management, with a focus on novel therapeutic strategies including checkpoint inhibitors and TKIs across lines of therapy. This page features news articles, interviews in written and video format, and podcasts that focus on unmet needs, treatment advances, and ongoing research in colorectal cancer.

Dr. Grothey Discusses Novel Agents for Colorectal Cancer

November 11th 2011

Dr. Axel Grothey from the Mayo Clinic Discusses Novel Agents for Colorectal Cancer

Colorectal Cancer: A Review

November 10th 2011

Colorectal cancer is the third most common type of cancer diagnosed in the United States and is the third most common cause of cancer-related death.

Prudent Diet May Help Prevent Colorectal Adenomas in Black Women

November 8th 2011

Investigators are recommending that black women follow a 'prudent dietary pattern' in lieu of a more Western-style diet to prevent the development of colorectal adenomas.

Progress Made, but More Work Lies Ahead in CLL and CRC Treatment

October 31st 2011

A look at the benefits of the chemoimmunotherapy rituximab for CLL and a look at the treatments and advances made in treating metastatic CRC.

Metastatic Colorectal Cancer Study Demonstrates Improved Overall Survival

October 26th 2011

A late phase metastatic colorectal cancer trial was stopped after demonstrating a statistically significant improvement in OS.

Aflibercept Improves Survival in Metastatic Colorectal Cancer Patients

September 26th 2011

Aflibercept added to FOLFIRI chemotherapy improved PFS and OS in previously treated patients with metastatic colorectal cancer.

Noninvasive Stool Test Effectively Detects Colon Cancer

September 19th 2011

The iFOBT test examines the stool for hidden blood, which could come from anywhere in the GI tract, and possibly indicates a colon tumor or precancerous growths known as polyps.

Number of Lymph Nodes Examined for Colon Cancer Increases but Proportion of Node-Positive Cancers Does Not

September 14th 2011

A greater number of lymph nodes are being screened in colon cancer but this has not led to more diagnoses of node-positive colon cancer.

Jury Still Out on Oxaliplatin for Early-Stage Colon, Rectal Cancers

July 26th 2011

Adding oxaliplatin to 5-fluorouracil before and after surgery for the treatment of locally advanced rectal cancer is demonstrating significant benefit.

5 Abstracts Offer Snapshot of Immunology Research

July 15th 2011

The field of immunotherapy is brimming with questions that researchers are working to answer, and many of those efforts were on display at the ASCO annual meeting.

Colon Cancer Screening Saves Lives Yet Screening Rates Remain Below Standard

July 7th 2011

Almost 1 in 3 adults in the United States do not get screened regularly.

Patient Navigation Boosts Colorectal Cancer Screening Rate in Ethnically Diverse Patients

July 1st 2011

A recent study showed that a patient-navigation-based intervention may help increase the rate of CRC screening in typically underserved groups, including low-income, ethnically diverse patients.

Dr. Scher Discusses Circulating Tumor Cells

June 23rd 2011

Dr. Howard Scher form Memorial Sloan-Kettering Cancer Center Discusses Circulating Tumor Cells

Two or More Drinks a Day Increases Colorectal Cancer Risk

May 6th 2011

New data suggest that individuals who drink moderate amounts of alcohol have an increased likelihood of developing colorectal cancer

Speculating Spectrum: More buzz about stock prices than the recently approved Fusilev indication

May 5th 2011

Spectrum Pharmaceuticals stock prices are the biggest story across the internet, not the FDA's approval of Fusilev

Aflibercept Delivers Positive Results in Colorectal Trial

April 29th 2011

Aflibercept, an investigational angiogenesis inhibitor, improved overall survival as a second-line treatment for patients with mCRC

PARP Inhibitors May Help Fight Colon Cancer

April 28th 2011

A class of drugs that has shown encouraging results in breast and ovarian cancers with BRCA gene mutations may also benefit patients who have colorectal cancers

ASCO GI Coverage: Delaying Chemotherapy Increases the Mortality Risk of Patients with Colon Cancer

March 14th 2011

The results of a systematic review and meta-analysis suggest that the mortality risk for colon cancer patients begins to increase with any avoidable delay in adjuvant chemotherapy beyond 4 weeks.

Laura Metcalfe on Colorectal Screening

March 12th 2011

Laura Metcalfe, MSN, RN, APN, C, AOCNS Advanced Practice Nurse, GI Division from John Theurer Cancer Center on Colorectal Screening

Technology for the Taking at Research Hub in Scotland

March 9th 2011

The University of Glasgow will begin offering medical and scientific research findings, including cancer-related discoveries, to businesses and entrepreneurs free of charge